|
**Overview**: Leptospira Antibodies Panel**Introduction**: The Leptospira Antibodies Panel is a diagnostic tool designed to screen for leptospirosis using serum samples. In India, leptospirosis causes ~50,000â€"100,000 cases annually (higher during monsoon in rural/flood-prone areas), with high mortality (~10-20 percent in severe Weil's disease) due to jaundice, renal failure, and hemorrhage. High morbidity from under-testing in rural/low-SES farmers/fishermen with fever, myalgia, or jaundice, limited serology labs, delayed doxycycline leading to multi-organ failure. Per microbiology practices aligned with ICMR and National Centre for Disease Control guidelines, the test employs immunoassay for Leptospira IgG and IgM over 1-2 days with high specificity, valuable for acute and convalescent diagnosis. This diagnostic falls under infection screening and targets patients with fever, conjunctival suffusion, or exposure to contaminated water, addressing accurate detection to guide antibiotic therapy and public health reporting. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise leptospirosis identification and reducing outbreak mortality. Its serum-based approach ensures reliable antibody detection.**Other Names**: Leptospira Ab Pnl.**FDA Status**: FDA approved, CLIA certified for microbiology/immunology, compliant with 2025 standards.**Historical Milestone**: MAT/IgM ELISA standard; in India, key in monsoon surveillance.**Purpose**: The test assesses 2 parameters including Leptospira IgG to guide leptospirosis screening, detect acute/past infection, inform antibiotic therapy.**Test Parameters**: 1. Leptospira IgG, 2. Leptospira IgM.**Pretest Condition**: No fasting required; patients should report fever or water exposure.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on fever, jaundice, animal/water contact.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated leptospirosis including renal failure, benefits of screening, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or early sampling can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Positive IgM indicates acute infection; IgG positive past exposure, necessitating specialist input.**Specialist Consultation**: Infectious disease specialists should be consulted for management.**Additional Supporting Tests**: MAT, PCR for confirmation.**Test Limitations**: Cross-reactivity possible; comprehensive approach required.**References**: Indian Journal of Medical Microbiology 2024, Leptospirosis Studies India 2023. |
